Navigation Links
Study: Surefire Medical's Technology Improves Delivery Of Embolics In Cancer Treatment
Date:3/6/2013

WESTMINSTER, Colo., March 6, 2013 /PRNewswire/ -- Surefire Medical's new infusion system maximizes delivery of drugs directly to the tumor site while minimizing potential damage to non-target organs, according to a new study.  The ability to more safely and efficiently deliver embolic agents to target tumors locally marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.

The 29 procedure study, led by Steven Rose , M.D. of the University of California at San Diego Medical Center (UCSD) and reported in CardioVascular and Interventional Radiology, determined that when the unique Surefire expandable anti-reflux tip is deployed, an approximate 20 mm Hg pressure drop occurs downstream from the tip, causing a reversal of blood flow in arteries between the liver and adjacent organs.  This phenomenon prevents the chemoembolization or radioembolization agents from flowing into downstream non-target vessels. 

"These results show that the new catheter technology makes it possible to prevent embolics from traveling to distal non-target vessels," said Rose. "We may potentially see improved patient outcomes because all blood flow carrying the embolics is directed to the liver while protecting the rest of the body."

The Surefire catheter's unique expandable tip also enables more of the embolic agents to reach their intended destination.

"Dr. Rose has identified a unique property of the Surefire Infusion System that is not available with standard end-hole catheters," said Aravind Arepally , M.D., Surefire Medical's Chief Scientific Officer.  "This should provide additional arsenal for doctors performing liver directed therapies."

According to Rose, the Surefire Infusion System provides both upstream and downstream protection.

"We are extremely pleased that the growing body of clinical evidence, coupled with the enthusiasm of our increasing user base at hospitals worldwide, continues to prove the efficacy of the Surefire line of catheters," said Surefire Medical CEO Jim Chomas .

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.

 


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
2. Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust
3. Clinical Study: Dietary Supplement SagaPro Reduces Frequent Urination
4. WebMD Study: U.S. Doctors Deeply Divided on Many Matters of Ethical Ambiguity
5. Prostate Cancer Study: Most Patients Report Satisfaction After Robotic Surgery
6. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
7. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
8. Christopher Mennone Joins Surefire Medical Team As International Business Director
9. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
11. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017 /PRNewswire/ ... developing first-in-class therapies for both rare and common ... million Series B financing. The company intends to ... for cirmtuzumab and TK216, and to advance preclinical ... program. Cirmtuzumab is a first-in-class anti-ROR1 ...
(Date:2/22/2017)... NetworkNewsWire Editorial Coverage: The cannabis industry is heating up. More ... legalized marijuana for medicinal or recreational use, and several countries, including ... Jamaica , Mexico , ... and the Netherlands , have also ... years. As a result, the cannabis industry has become ripe with ...
(Date:2/22/2017)... BEACH, Florida , February 22, 2017 /PRNewswire/ ... Cannabis Industries is becoming more and more prevalent ... Of Cannabinoids & THC Extracts as well as ... approach to medicinal cannabis and marijuana therapies and ... acquiring new relationships and assets designed to bring ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified CBD ... the mouth into the bloodstream. Far outpacing the absorption speed of ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine ... practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to ... number of neurosurgeons in Michigan performing minimally invasive back surgery that often results ...
(Date:2/22/2017)... CT (PRWEB) , ... February 22, 2017 , ... The ... and the 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A ... webinar is part of the Interactive Webinar Series. , If you want to find ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a home ... University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, March ... Aging is a tremendous resource in our community. We are thrilled to participate in ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... number of African American/Black students who want to become physicians. PMF also provides ... careers as physicians in the Oakland/San Francisco Northern California, Bay Area. PMF’s mission ...
Breaking Medicine News(10 mins):